MK021 (Completed)
A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess Anacetrapib When Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low HDL-C
- Medicine
- Anacetrapib
- Population
- Diabetes mellitus
- Phase
- III
- Starting year
- 2012